Browse the evidence

Weight loss induced by a low-calorie diet resulted in an increase in serum 25-hydroxyvitamin D (25(OH)D) in both women and men by 12 nmol/L and 13 nmol/L respectively.

Weight loss through a low-calorie diet can improve vitamin D levels in individuals with obesity.

Further weight loss during the intervention had an additional beneficial impact on serum 25(OH)D in women.

Encouraging further weight loss in women may enhance vitamin D status.

Initial low serum 25(OH)D was associated with successful weight loss maintenance in women but not men.

Monitoring vitamin D levels may be important for weight loss maintenance strategies in women.

A significant proportion of patients with diabetes and hypertension experienced remission after ESG.

ESG may help improve metabolic health in overweight patients with these conditions.

Mean sedentary bout times were significantly associated with higher percent body-fat in women (b=1.09, 95% CI 0.16 to 2.03, p=0.02), but not men.

Practitioners should consider the duration of sedentary bouts when addressing body-fat in women.

The negative association of higher total number of sedentary bouts with percent body-fat approached significance in women (b=−0.07, −0.14 to 0.00, p=0.06), but not men.

Encouraging more breaks in sedentary behavior may benefit women's body-fat levels.

These findings provide preliminary evidence on the potential importance for human health of avoiding prolonged periods of being sedentary, independent of physical activity.

Reducing prolonged sedentary time may enhance overall health.

Exercise-related energy compensation occurs independent of metabolic adaptation.

This indicates that practitioners should not expect metabolic adaptations to accompany energy compensation from exercise.

It is questionable whether combining BFR with traditional aerobic training can preserve or potentiate hypertrophic adaptations.

Practitioners should be cautious when combining BFR with aerobic training, as the effects on hypertrophy are not well established.

Semaglutide treatment led to larger reductions in glycated hemoglobin levels compared to the control group (−1.3% vs. −0.6%; P <0.001).

Semaglutide may improve glycemic control in patients post-ablation.

Higher intake of white rice (≥450g/d compared with <150g/d) is associated with an increased risk of diabetes (HR: 1.20; 95% CI: 1.03-1.41, p for trend=0.003).

Practitioners should consider advising moderation in white rice consumption to mitigate diabetes risk.

The highest risk of diabetes associated with white rice intake was observed in South Asia (HR: 1.65; 95% CI: 1.17-2.34, p for trend=0.02).

Healthcare providers in South Asia should be particularly aware of the risks associated with high white rice consumption.

Delaying breakfast from 0700 h to 0930 h or 1200 h reduces postprandial glycaemia.

Practitioners can recommend delaying breakfast to improve glycaemic control in patients with type 2 diabetes.

The metabolic phenotype can be modified and affects the fate of ingested energy.

Practitioners should recognize that metabolic adaptations can influence weight management strategies.

Durable LVAD patients treated with GLP-1 RA had a significant weight reduction from 116 kg to 110 kg (p-value < 0.001).

GLP-1 RA may be effective for weight management in LVAD patients.

White rice intake is associated with a 18% increased risk of type 2 diabetes mellitus (T2DM) when comparing the highest with the lowest category of intake.

Practitioners should consider the potential increased risk of T2DM when advising on white rice consumption.

Every additional 150 grams of white rice intake per day is associated with a 6% greater risk of T2DM.

Increasing white rice intake may elevate T2DM risk, which should be considered in dietary recommendations.

Incretin-based anti-obesity medications are gaining interest for their potential role in preconception care.

Healthcare providers should consider the use of incretin-based medications in preconception counseling.

Ninety-day medical complications were significantly reduced in GLP-1 RA users across BMI categories ≥25.

Practitioners may consider GLP-1 RA use to reduce post-operative complications in obese patients.

Two-year surgical complications were lower among GLP-1 RA users in BMI 35 to 39.9 and ≥40 groups.

GLP-1 RA may be beneficial for reducing long-term surgical complications in higher BMI patients.

GLP-1 RA use was associated with significantly reduced risk of revision at 10 years in the 25.0 to 29.9 BMI group.

Consideration of GLP-1 RA may improve long-term surgical outcomes in patients with lower BMI.

Semaglutide improved lipid parameters, including reductions in LDL cholesterol and non-HDL cholesterol levels.

Semaglutide may be beneficial for improving lipid profiles in patients with T2DM.

Lifestyle interventions demonstrate favorable effects on lipid metabolism independent of weight loss.

Encourage patients to adopt lifestyle changes for lipid management, even if weight loss is not achieved.

GLP-1 receptor agonists (GLP-1 RAs) have been presumed to positively influence erectile function.

GLP-1 RAs may be considered in the management of erectile function in diabetic patients.